Envoy Medical (COCHW) Accumulated Depreciation & Amortization (2023 - 2026)

Envoy Medical's Accumulated Depreciation & Amortization history runs 4 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 5.95% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 5.95% YoY), while the FY2025 annual figure was $5.1 million, up 5.78% from the prior year.
• Accumulated Depreciation & Amortization came in at $5.2 million for Q1 2026 at Envoy Medical, up from $5.1 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.2 million in Q1 2026 to a low of $4.7 million in Q4 2023.
• A 4-year average of $5.0 million and a median of $5.0 million in 2025 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization rose 3.71% in 2024 and grew 5.95% in 2026, its largest moves.
• Envoy Medical's Accumulated Depreciation & Amortization stood at $4.7 million in 2023, then gained by 3.71% to $4.8 million in 2024, then advanced by 5.78% to $5.1 million in 2025, then grew by 1.43% to $5.2 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $5.2 million, $5.1 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison